Andrea Foli

5.5k total citations
99 papers, 3.5k citations indexed

About

Andrea Foli is a scholar working on Molecular Biology, Infectious Diseases and Genetics. According to data from OpenAlex, Andrea Foli has authored 99 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Molecular Biology, 26 papers in Infectious Diseases and 25 papers in Genetics. Recurrent topics in Andrea Foli's work include Amyloidosis: Diagnosis, Treatment, Outcomes (68 papers), HIV Research and Treatment (23 papers) and HIV/AIDS drug development and treatment (22 papers). Andrea Foli is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (68 papers), HIV Research and Treatment (23 papers) and HIV/AIDS drug development and treatment (22 papers). Andrea Foli collaborates with scholars based in Italy, United States and Germany. Andrea Foli's co-authors include Giampaolo Merlini, Giovanni Palladini, Paolo Milani, Marco Basset, Francesca Lavatelli, Franco Lori, Laura Obici, Julianna Lisziewicz, Stefano Perlini and Mario Nuvolone and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Andrea Foli

95 papers receiving 3.4k citations

Peers

Andrea Foli

GENET

EPIDE

NEPHR

ONCOL

M Tulliez France

Byron M. Espina United States

Margarita López‐Trascasa Spain

Dale L. Bixby United States

Laurent Garderet France

Florian Emmerich Germany

Bertold Emmerich Germany

Celalettin Üstün United States

Kiyoshi Kitano Japan

B. Grosbois France

M Tulliez France

Andrea Foli

860 ×0.3

1.4k ×1.5

GENET

771 ×1.0

EPIDE

32 ×0.0

NEPHR

1.9k ×3.0

ONCOL

Citations per year, relative to Andrea Foli Andrea Foli (= 1×) peers M Tulliez

Countries citing papers authored by Andrea Foli

Since Specialization

Citations

This map shows the geographic impact of Andrea Foli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Foli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Foli more than expected).

Fields of papers citing papers by Andrea Foli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Foli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Foli. The network helps show where Andrea Foli may publish in the future.

Co-authorship network of co-authors of Andrea Foli

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Foli. A scholar is included among the top collaborators of Andrea Foli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Foli. Andrea Foli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Basset, Marco, Giuseppe D. Sanna, Andrea Foli, et al.. (2025). Daratumumab‐based regimens versus CyBorD in newly diagnosed patients with AL amyloidosis and IIIb cardiac stage: A matched case‐control study. HemaSphere. 9(3). e70112–e70112. 1 indexed citations

Basset, Marco, Mario Nuvolone, Andrea Foli, et al.. (2025). Diffuse lung involvement as a rare presentation of systemic AL amyloidosis: a retrospective cohort study. Blood Advances. 9(9). 2221–2225.

Basset, Marco, Paolo Milani, Andrea Foli, et al.. (2022). Early cardiac response is possible in stage IIIb cardiac AL amyloidosis and is associated with prolonged survival. Blood. 140(18). 1964–1971. 15 indexed citations

Basset, Marco, Paolo Milani, Mario Nuvolone, et al.. (2020). Sequential response-driven bortezomib-based therapy followed by autologous stem cell transplant in AL amyloidosis. Blood Advances. 4(17). 4175–4179. 18 indexed citations

Milani, Paolo, Marco Basset, Paola Curci, et al.. (2020). Daratumumab in light chain deposition disease: rapid and profound hematologic response preserves kidney function. Blood Advances. 4(7). 1321–1324. 25 indexed citations

Ami, Diletta, Paolo Mereghetti, Andrea Foli, et al.. (2019). ATR-FTIR Spectroscopy Supported by Multivariate Analysis for the Characterization of Adipose Tissue Aspirates from Patients Affected by Systemic Amyloidosis. Analytical Chemistry. 91(4). 2894–2900. 25 indexed citations

Palladini, Giovanni, Paolo Milani, Andrea Foli, et al.. (2017). Presentation and outcome with second-line treatment in AL amyloidosis previously sensitive to nontransplant therapies. Blood. 131(5). 525–532. 41 indexed citations

Palladini, Giovanni, Paolo Milani, Andrea Foli, et al.. (2017). A phase 2 trial of pomalidomide and dexamethasone rescue treatment in patients with AL amyloidosis. Blood. 129(15). 2120–2123. 69 indexed citations

Palladini, Giovanni, Marco Basset, Paolo Milani, et al.. (2017). Biomarker-Based Screening of Organ Dysfunction in Patients with MGUS Allows Early Diagnosis of AL Amyloidosis. Blood. 130. 1760–1760. 6 indexed citations

10.

Russo, Paola, Giovanni Palladini, Andrea Foli, et al.. (2011). Liver involvement as the hallmark of aggressive disease in light chain amyloidosis: distinctive clinical features and role of light chain type in 225 patients. Amyloid. 18(sup1). 92–93. 20 indexed citations

11.

Palladini, Giovanni, Alessandra Barassi, Catherine Klersy, et al.. (2010). The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosis. Blood. 116(18). 3426–3430. 160 indexed citations

12.

Paolucci, Stefania, Andrea Foli, Roberto Gulminetti, et al.. (2009). HIV-1 Plasma Variants Encoding Truncated Reverse Transcriptase (RT) in a Patient With High RT-Specific CD8+ Memory T-Cell Response. Current HIV Research. 7(3). 302–310. 3 indexed citations

13.

Calarota, Sandra A., Andrea Foli, Renato Maserati, et al.. (2008). HIV-1-Specific T Cell Precursors with High Proliferative Capacity Correlate with Low Viremia and High CD4 Counts in Untreated Individuals. The Journal of Immunology. 180(9). 5907–5915. 40 indexed citations

14.

Shepard, Brett D., David McNamara, Andrea Foli, et al.. (2008). Beneficial Effect of TRAIL on HIV Burden, without Detectable Immune Consequences. PLoS ONE. 3(8). e3096–e3096. 10 indexed citations

15.

Lori, Franco, Richard B. Pollard, Lucia Whitman, et al.. (2005). Lowering the Dose of Hydroxyurea Minimizes Toxicity and Maximizes Anti-HIV Potency. AIDS Research and Human Retroviruses. 21(4). 263–272. 9 indexed citations

16.

Foli, Andrea, Federica Benvenuto, Giampiero Piccinini, et al.. (2001). Direct analysis of mitochondrial toxicity of antiretroviral drugs. AIDS. 15(13). 1687–1694. 60 indexed citations

17.

Foli, Andrea, Franco Lori, Renato Maserati, et al.. (1997). Hydroxyurea and didanosine is a more potent combination than hydroxyurea and zidovudine.. PubMed. 2(1). 31–8. 26 indexed citations

18.

Antoni, Anna De, Andrea Foli, Julianna Lisziewicz, & Franco Lori. (1997). Mutations in thepolGene of Human Immunodeficiency Virus Type 1 in Infected Patients Receiving Didanosine and Hydroxyurea Combination Therapy. The Journal of Infectious Diseases. 176(4). 899–903. 85 indexed citations

19.

Pluda, James M., Andrea Foli, M. Wayne Saville, et al.. (1995). Phase I/II study of intermittent all-trans-retinoic acid, alone and in combination with interferon alfa-2a, in patients with epidemic Kaposi's sarcoma.. Journal of Clinical Oncology. 13(8). 1966–1974. 40 indexed citations

20.

Gobbo, V. Del, Andrea Foli, Jan Balzarini, et al.. (1991). Immunomodulatory activity of 9-(2-phosphonylmethoxyethyl)adenine (PMEA), a potent anti-HIV nucleotide analogue, on in vivo murine models. Antiviral Research. 16(1). 65–75. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact